These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2383524)

  • 41. Gastric emptying of liquid before and after gastroplasty for morbid obesity.
    Miskowiak J; Andersen B; Munck O
    Scand J Gastroenterol; 1985 Jun; 20(5):583-8. PubMed ID: 4023622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and weight reduction do not influence gastric emptying and antral motility.
    Hutson WR; Wald A
    Am J Gastroenterol; 1993 Sep; 88(9):1405-9. PubMed ID: 8362840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International trial of long-term dexfenfluramine in obesity.
    Guy-Grand B; Apfelbaum M; Crepaldi G; Gries A; Lefebvre P; Turner P
    Lancet; 1989 Nov; 2(8672):1142-5. PubMed ID: 2572857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ; Jamieson GG; Myers JC; Collins PJ
    Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influences of fat restriction and lipase inhibition on gastric emptying in obesity.
    Mathus-Vliegen EM; van Ierland-van Leeuwen ML; Bennink RJ
    Int J Obes (Lond); 2006 Aug; 30(8):1203-10. PubMed ID: 16462818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of gastric emptying after gastric bypass surgery using radionuclides.
    Horowitz M; Cook DJ; Collins PJ; Harding PE; Hooper MJ; Walsh JF; Shearman DJ
    Br J Surg; 1982 Nov; 69(11):655-7. PubMed ID: 7127049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus.
    Jones KL; Horowitz M; Wishart MJ; Maddox AF; Harding PE; Chatterton BE
    J Nucl Med; 1995 Dec; 36(12):2220-8. PubMed ID: 8523109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.
    Weissman NJ; Tighe JF; Gottdiener JS; Gwynne JT
    N Engl J Med; 1998 Sep; 339(11):725-32. PubMed ID: 9731088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
    Enzi G
    Ter Arkh; 1997; 69(5):71-5. PubMed ID: 9235665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fenfluramine anorexia: a peripheral locus of action.
    Davies RF; Rossi J; Panksepp J; Bean NJ; Zolovick AJ
    Physiol Behav; 1983 May; 30(5):723-30. PubMed ID: 6878478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M; Pisculli M; Petraroli AR; Riganelli S; Saracino A; Siani V
    Clin Ter; 1990 Jun; 133(5):289-97. PubMed ID: 2143712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of calcitonin on gastric emptying after isotope-labeled solid meal in patients with stomach ulcer].
    Jonderko G; Jonderko K; Gołab T
    Pol Arch Med Wewn; 1990 Dec; 84(6):357-62. PubMed ID: 2092324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The addition of locust bean gum but not water delayed the gastric emptying rate of a nutrient semisolid meal in healthy subjects.
    Darwiche G; Björgell O; Almér LO
    BMC Gastroenterol; 2003 Jun; 3():12. PubMed ID: 12793910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastric emptying, CCK release, and satiety in weight-stable obese subjects.
    Mathus-Vliegen EM; Van Ierland-Van Leeuwen ML; Roolker W
    Dig Dis Sci; 2005 Jan; 50(1):7-14. PubMed ID: 15712629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric emptying and obesity.
    Wright RA; Krinsky S; Fleeman C; Trujillo J; Teague E
    Gastroenterology; 1983 Apr; 84(4):747-51. PubMed ID: 6825986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of gastric emptying and feeding by fenfluramine.
    Robinson PH; Moran TH; McHugh PR
    Am J Physiol; 1986 May; 250(5 Pt 2):R764-9. PubMed ID: 3706564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Is fenfluramine suitable as a therapeutic principle in obese aged diabetics? (end)].
    Förster H; Huth K; Koch E; Tunali G
    Fortschr Med; 1979 Feb; 97(6):259-62. PubMed ID: 428867
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of dexfenfluramine on body weight, blood pressure, insulin resistance and serum cholesterol in obese individuals.
    Holdaway IM; Wallace E; Westbrooke L; Gamble G
    Int J Obes Relat Metab Disord; 1995 Oct; 19(10):749-51. PubMed ID: 8589769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of intragastric balloon on gastric emptying time in humans for weight control.
    Su HJ; Kao CH; Chen WC; Chang TT; Lin CY
    Clin Nucl Med; 2013 Nov; 38(11):863-8. PubMed ID: 24089058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of fenfluramine on food intake, body weight, gastric emptying and brain monoamines in Syrian hamsters.
    Rowland NE; Carlton J
    Brain Res Bull; 1986 Oct; 17(4):575-81. PubMed ID: 2430682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.